Easily injectable biomaterial technology to induce and localize regulatory T cells to specific tissues and sustain their pro-regenerative activities in tissue regeneration with a focus on musculoskeletal diseases and injuries.

North America Dental Biomaterials Market Size and Overview North America Dental Biomaterials Market size was valued at USD 6.5 Billion in 2025 and is poised to grow from USD 6.

North America Dental Biomaterials Market Size and Overview North America Dental Biomaterials Market size was valued at USD 6.5 Billion in 2025 and is poised to grow from USD 6.

We're delighted to welcome Khoon Lim to the #BiomaterialsScience Editorial Board as an Associate Editor! Find out more about Khoon's research in our article below 👇 European Society For Biomaterials...

Reported Monday, Nov 9 - 9:13am EST (TheFly subscription required to read more.)

Plants synthesize diverse phenylpropanoids, which provide us essential medicine, nutrients, and biomaterials while also acting as a major global ca...

The Global Orthopaedic Biomaterials Market size is expected to reach US$ 47.83 billion by 2034, increasing from US$ 23.97 billion in 2025. The market is anticipated to register a compound annual growth rate (CAGR) of 7.98% during 2026–2034. Rising demand for joint reconstruction, fracture fixation, spinal implants, and bone regeneration solutions is supporting the development of advanced biomaterials across the healthcare industry.

AbstractTime-of-flight secondary ion mass spectrometry (ToF-SIMS) provides high-resolution, label-free chemical imaging. Direct chemical characterization inside enclosed microchannels remains challenging because opening the device can alter the sample surface and spatial information. In this study, we present a tape-based microfluidic chip that enables direct ToF-SIMS analysis of biomaterials within enclosed microchannels. The chip uses a thin, polymeric membrane as a removable sealing layer, which maintains microfluidic integrity during operation and can be selectively removed by a 20 keV Ar2600+ beam to expose the sample surface. Our novel tape-based chip concept eliminates the need for cleanroom fabrication and allows a straightforward transition from microfluidic experiments to vacuum-based analysis. As a case study, the chip was validated by detecting model compounds in gelatin methacrylate (GelMA) hydrogels: moxifloxacin (MXF, ∼401 Da), an antibiotic molecule, and poly(styrene sulfonate) (PSS, Mw ≈ 70, 000), a high-molecular-weight polyelectrolyte. The design supports in situ chemical imaging of biomaterials and can be applied to investigate molecular interactions, drug transport, and tissue responses in engineered microenvironments at room temperature. Additionally, the method could be adapted for Cryo-SIMS, enabling the analysis of biological samples in a near-native state. This work presents a practical and cost-effective strategy for integrating microfluidic chips with surface-sensitive mass spectrometry, enabling new opportunities in biomaterials characterization and pharmaceutical research.

North America Hyaluronic Acid-based Biomaterials Market Size and Overview North America Hyaluronic Acid-based Biomaterials Market size was valued at USD [2025 VALUE] Billion in 2025 and is poised to g...

UCL Discovery is UCL's open access repository, showcasing and providing access to UCL research outputs from all UCL disciplines.

Indian biomaterials startup AltM, founded by Tesla alums, has raised $10.3M to scale up its tech that converts farm waste into specialty materials for cosmetics, beauty, packaging, textiles, and other industries. Bengaluru-based firm AltM, which converts agricultural waste into bio-based materials, has closed a $10.3M Series A funding round to expand its R&D and manufacturing operations. The investment welcomed new backers Rainmatter by Zerodha and Mela Ventures, who joined existing shareholders Omnivore, Theia Ventures, Aureolis Ventures, Spectrum Impact, and strategic angel investors. Founded by two former Tesla manufacturing executives, AltM will use the funds to move from pilot production to commercial-scale manufacturing, expand its R&D and customer qualification programmes, and grow its engineering and commercial teams. The startup’s technology turns agricultural residues into high-performance sustainable materials and molecules for a host of industries, including beauty and personal care, textiles, industrial chemicals, construction, packaging, and consumer goods. “Rewiring foundational supply chains away from fossil-derived inputs is one of the most critical challenges facing modern manufacturing today,” said Abhinav Negi, climate and deep tech lead at Rainmatter by Zerodha. The AltM team has demonstrated outstanding technical depth alongside strict commercial discipline, and we are proud to support their long-term vision to build...